Kiora Pharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview

Kiora Pharmaceuticals

12/11/2021 21:38

* Kiora Pharmaceuticals Inc  KPRX.OQ   KPRX.O  is expected
to show no change in quarterly revenue when it reports 
results on November 15 (estimated). 
​* Refinitiv's mean analyst estimate for Kiora Pharmaceuticals
Inc is for a loss of 34 cents per share. For the same quarter
last year, the company reported a loss of 44 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $11​, about 86.1% above​ its last closing
price of $1.53. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.41       -0.42      -0.35     Beat    16
 Mar. 31 2021  -0.39       -0.38      -0.37     Beat    3.9
 Dec. 31 2020  -0.44       -0.44      -0.52     Missed  -18.2​
 Sep. 30 2020  -0.42       -0.42      -0.44     Missed  -4.8
 ​​Jun.        -0.43       -0.43      -0.38     Beat    11.6
 30 2020                                                
                                                        ​
 Dec. 31 2019  -0.81       -0.81      -0.71     Beat    11.7
 This summary was machine generated November 12 at 21:38 GMT. 
All figures in US dollars  unless otherwise stated